Return to Excellus Brokers News

Rx News - Navigating The GLP-1 Trend

Diabetes is one of the top trend drivers of pharmacy costs due to the growing diabetic population and newer, more expensive therapies recommended earlier in the treatment plan. Since 2006, medications like Ozempic® and Trulicity® have been used to treat Type 2 Diabetes. Today, they are gaining popularity as celebrities and social media influencers tout their weight loss benefits.

As a health plan committed to providing access to high-quality and affordable health care, the rising trend of GLP-1 therapies demands careful consideration.

Read The Full Article

With Rx News we include information about our innovative new pharmacy programs, drug regulation updates, pharmacy trends and more. We explore different topics to help you keep current with this ever-evolving area of coverage.

For more articles, view the Rx News Archive →
Select "Rx News" from the Category drop down.


Healthy New York Business Applications And Recertifications For Small Group

About ACQAs: Broker Training

Online Chat Now Available On Davis Vision Website

May Is Mental Health Awareness Month

Rx News - Save On Medical Benefit Specialty Drugs With Smart RxAssist




Broker Specific

Small Business

Midsize & Large Business



Individual Market Plan


Script for Excellus BCBS Employer/Broker News Archive/Article


GDPR Notification Content